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ABSTRACT 
 
We reviewed the evolution of concept of stigma, its correlates and consequences, and analysed 
psychometric instruments that were used to study personal experiences of stigma. We provided an 
insight over research of stigma in Portugal. We reviewed relevant studies that use Consumer 
Experiences of Stigma Questionnaire and documented psychometric properties of this instrument. 
Our study aimed both to explore experiences of stigma in a Portuguese sample of people with severe 
mental illness and to contribute to the assessment of the psychometric properties of Consumer 
Experiences of Stigma Questionnaire and to the validation of its Portuguese translation. 
We performed a cross sectional descriptive and analytic study, collected socio-demographic data and 
measured experiences of stigma and global functioning. 
Frequency of responses regarding stigma section of CESQ matched previous studies using that scale. 
Frequency of responses in discrimination section was slightly lower than previously reported studies. 
We found an association between the discrimination score of CESQ and both male gender and living in 
the community. The discrimination score also positively correlated with global functioning. 
Cronbach alphas for CESQ and its subscales were good. Intraclass correlation coefficients for CESQ and 
stigma subscale were also good. Using factor analysis we found most of the items in CESQ would fit 2 
factors, grossly corresponding to the previously defined subscales. 
We conclude that this study successfully explored stigma in Portugal, contributing in simultaneous to 
the validation of Consumer Experiences Questionnaire. 
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RESUMO 
 
Fizemos uma análise da evolução do conceito de estigma, das suas correlações e das suas consequências 
e analisámos os instrumentos psicométricos utilizados para estudar experiências pessoais de estigma. 
Revimos os principais estudos de investigação sobre estigma em Portugal. Revimos, igualmente, os 
estudos relevantes utilizando o “Consumer Experiences of Stigma Questionnaire” (CESQ) e as 
propriedades psicométricas já documentadas. 
O nosso estudo teve como objetivos: explorar as experiências de estigma numa amostra portuguesa de 
pessoas com perturbação mental grave e contribuir para a documentação das propriedades 
psicométricas do “Consumer Experiences of Stigma Questionnaire” e para a validação da sua versão 
portuguesa. 
Fizemos um estudo transversal, descritivo e analítico, recolhemos dados sociodemográficos e clínicos e 
medimos as experiências de estigma e o funcionamento global. 
A frequência das respostas da secção de estigma foi semelhante à dos restantes estudos utilizando a 
CESQ. A frequência das respostas na secção de discriminação foi ligeiramente inferior à reportada 
noutros estudos. Verificámos a existência de uma associação entre a pontuação da subescala de 
discriminação, o sexo masculino e o facto de se viver na comunidade. A pontuação da subescala de 
discriminação está também correlacionada de forma positiva com o funcionamento global. 
Os alfas de Cronbach para a CESQ e para as suas subescalas foram considerados bons. Os coeficientes de 
correlação intraclasse foram igualmente considerados igualmente bons.  
Utilizando técnicas de análise fatorial, verificámos que a maior parte dos itens da CESQ se enquadrava 
em dois fatores, correspondendo sensivelmente às subescalas definidas previamente. 
Concluímos que o presente estudo explorou com sucesso a questão do estigma em Portugal, 
contribuindo em simultâneo para a validação do “Consumer Experiences of Stigma Questionnaire.” 
 
  
RESUMEN 
 
Hicimos un análisis de la evolución del concepto de estigma, de sus correlaciones y de sus consecuencias 
y analizamos los instrumentos psicométricos utilizados para estudiar las experiencias personales de 
estigma. Revisamos los principales estudios de investigación de estigma en Portugal. 
Revisamos también los estudios relevantes utilizando “Consumer Experiences of Stigma Questionnaire” 
(CESQ) y sus propiedades psicométricas ya documentadas. 
Los objectivos de nuestro estudio fueran explorar las experiencias de estigma en una muestra 
portuguesa de personas con perturbación mental grave y contribuir para la documentación de las 
propiedades psicométricas de “Consumer Experiences of Stigma Questionnaire” y para la validación de 
su versión portuguesa.  
Hicimos un estudio transversal, descriptivo e analítico, cogemos datos sociodemográficos y clínicos y 
medimos las experiencias de estigma y el funcionamiento global. 
La frecuencia de las respuestas en la sección de estigma  fue parecida con la de los demás estudios 
utilizando la CESQ. La frecuencia de las respuestas en la sección de discriminación fue un poco más baja 
que en estudios anteriores. Verificamos la existencia de una asociación entre la puntuación de la sección 
de discriminación, género  masculino y la vivencia en comunidad. La puntuación de la sección de 
discriminación esta correlacionada positivamente con el funcionamiento global. 
Los alfas de Cronbach para la CESQ y para sus secciones fueran considerados buenos. Los coeficientes de 
correlación intraclases fueran considerados también buenos.  
Utilizando técnicas de análisis factorial, verificamos que la mayoría de los itens de la CESQ se 
encuadraba en dos factores, que correspondían sensiblemente a las subscalas definidas previamente. 
Concluimos que esto estudio ha demonstrado la cuestión del estigma en Portugal, y contribuyó  de 
forma simultanea para la validación del “Consumer Experiences of Stigma Questionnaire” 
  
 
“…All good people agree, 
 And all good people say, 
All nice people, like Us, are We 
 And every one else is They: 
But if you cross over the sea, 
 Instead of over the way, 
You may end by (think of it!) looking on We 
  As only a sort of They!” 
 
Rudyard Kipling, We and They, 1926 
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1 INTRODUCTION 
1.1 ABOUT STIGMA 
 
1.1.1 Why focus on stigma? 
 
Stigma is defined as a sign of disgrace or discredit. Authors agree it is a powerful negative 
attribute, having its impact on all social relations.  
Stigma is present everywhere in our society. It affects different characteristics in people, 
ranging from sexual orientation to HIV/AIDS, several medical disorders, gender, race, 
unemployment or obesity. However, in mental health disorders stigma has a  devastating 
impact1. 
Discrimination, the enactment of stigma, appears closely associated to it. While stigma lies at 
the base of discrimination, discriminatory practices also promote and reinforce stigma. 
Discrimination is also about the conditions in which patients live, mental health budgets and 
the priority which we allow these services to achieve.2 In other words, stigma and 
discrimination lead to social exclusion – a triad that is a key determinant in the mental health 
field. 
Stigma and discrimination are violations of human rights. Intention and commitment to fight 
stigma are present in the spirit of legally binding treaties. Examples of those are the  Universal 
Declaration of Human Rights (UDHR)3 , International Covenant on Civil and Political Rights 
(ICCPR)4, International Covenant on Economic, Social and Cultural Rights (ICESCR)5 and 
Convention Against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment 
(CAT)6. 
Fighting stigma and discrimination is explicitly mentioned on the Convention on the Rights of 
People with Disabilities (CRPD)7 . CRPD actually demands that signatories ‘take all appropriate 
measures to eliminate discrimination on the basis of disability by any person, organisation or 
private enterprise’, and to ‘adopt immediate, effective and appropriate measures … to combat 
stereotypes, prejudices and harmful practices relating to persons with disabilities … in all areas 
of life’.7 
From the part of the World Health Organization, tackling stigma, discrimination and social 
exclusion is currently a major concern of the General Assembly, which reflects in the  WHO 
Mental Health Action Plan 2013-20208.  
At regional level, in the European Union, commitment to fighting stigma and discrimination is a 
consequence of signing treaties like European Convention on Human Rights, European Social 
Charter, European Convention on the Prevention of Torture and Inhuman or Degrading 
Treatment or Punishment. Recommendation Rec (2004)10, of the Committee of Ministers to 
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member states, is very specific about the protection of the human rights and dignity of persons 
with mental disorder. 
Still at regional level, and in line with WHO Mental Health Action Plan, stigma and 
discrimination is one of the main action areas of  European Mental Health Action Plan.9 
At national level, fighting stigma, discrimination and social exclusion is a component of policies, 
plans and programs worldwide. For examples of anti-stigma programs, please see ASPEN 
Project country reports.10 
In a time when quality mechanisms tend to be implemented into healthcare systems, there is 
also a trend to develop parts of quality standards that have statements on fighting stigma at a 
local level. NICE quality standards are a good example in the United Kingdom.11 To implement 
stigma into quality standards is, by itself, a strategy to fight it, by turning each service user in a 
potential advocate, as Byrne noted2. 
Therefore, there is the need to foster the development of indicators that can be used regarding 
mental illness stigma. 
1.1.2 Evolution of the concept 
Stigma is a word that has its reminiscences in the Greek civilization. Stigma were body marks 
that were intentionally applied to individuals- the stigmatized - that carried unacceptable moral 
or individual traits, as compared to standards in that society. In Christian times, society has 
elaborated on the concept, adding two other meanings to those body marks – to indicate a holy 
grace or to indicate a sign of deformity/physical disease.12 Anyway, those times, stigma implied, 
from the social point of view, firstly,  “imputing a meaning into something” even if it did not 
have that meaning, and, secondly, dealing with deviations to a social norm.12 
Goffmann12 was the first author to theorize stigma. To Goffmann, stigma is the result of a gap 
between perceived attributes and stereotypes. It is a matter of perspective, not reality. it is “in 
the eye of the beholder”. Stereotypes are selective perceptions that categorize people, and 
that exaggerate differences between groups (‘them and us’) in order to obscure differences 
within groups.13 
 He defines three types of attributes: 
 Body(physical) – e.g. visible deformities in the body, deformity caused by physical 
disease 
 Character  (personal) – e.g. mental illness, criminal conviction 
 Tribal (Social) – e.g. stigma of one group against another. 
Goffmann also distinguishes between “discredited” and discreditable”. Those concepts were 
further developed by  Jones et al.14 , who proposed six dimensions of stigma: 
 Concealability indicates how evident or visible the characteristic is to other people.  
 Course concerns over reversibility over time, regarding stigmatizing disorder. 
Irreversible conditions cause more negative attitudes than others. 
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 Disruptiveness indicates the extent to which a mark blocks or weakens interpersonal 
relations.  
 Aesthetics reflects what is good-looking or attractive to one's perceptions. When 
applied to stigma, it means whether a mark provokes a reaction of aversion. 
 Origin refers to how the condition began. Perceived responsibility on the conditions will 
carry more negative attitude. 
 Peril, refers to feelings of threat induced in other people. This can mean physical threat 
(as in “contamination”) or simply being uncomfortable. 
According to Byrne, stigma is connoted with a few negative attributes. Shame is its first 
expression, resulting from perception as indulgence or as a weakness, despite centuries of 
knowledge, media campaigns and “the decade of the brain”. Blame is also an attitude that 
appears associated to shame.2  Maintaining secrecy is the maladaptive way some people find to 
cope with shame, but it can lead to deleterious consequences.  
1.1.3 Development of stigma 
According to Byrne, 2 negative attitudes towards people with mental illness exist since 
playschool and extend into early adulthood. This is suggested by several studies: Weiss15 
examined a cohort of children of elementary school age and confirmed the prejudices eight 
years after;   Green16 compared different studies, focusing public stigma, published within 22 
years  time. He found out that the results were remarkably consistent across all studies, which 
seemed to indicate that the community maintained consistent, long lasting negative attitudes towards 
the mentally ill. For Byrne,2 this seems to object the common belief that with increased scientific 
knowledge about mental illness, stigma would tend to disappear. 
1.1.4 Different concepts of stigma 
The concept of stigma has evolved in the last fifteen years. 
Link and Phelan have added discrimination to Jones’ original dimensions.17 Still, in 2001 the 
same authors present two major challenges for the concept of stigma.  
The first challenge is that researchers who study stigma do so from their vantage point, 
privileging their own scientific theories and investigation methods rather than words and 
observations about people they study. This may lead to misunderstanding of the experience of 
people being stigmatized and to perpetuation of assumptions that are unsubstantiated. 
 The second challenge is about individualization of stigma and the fact that in research it tends 
to be considered as an attribute or a mark of the person rather than a designation or tag that 
others attach to an individual.  
Thus, these authors propose a definition of stigma based on a convergence a few 
components:17 
 Distinguishing and labelling human differences – oversimplification of salient differences 
between human beings occurs, with further labelling of individuals. 
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 Associating human differences to negative attributes – labels previously mentioned are 
associated to negative stereotypes, as previously described by Goffmann. Categories 
and stereotypes are often “automatic” and facilitate “cognitive efficiency”. For the 
authors, from a psychological standpoint, culturally given categories are present even at 
a preconscious level and provide people with a means of making shorthand decisions 
that free them to attend to other matters. 
 Separating “us from them” – Social labels connote a separation between the group that 
stigmatizes (“us”) and the group that is being stigmatized (“them”). For example, some 
people talk about people who have schizophrenia as being “schizophrenics”.  
 Status loss and discrimination – stigma leads to loss of status in social hierarchy, and to 
discrimination, both at individual and at structural levels. 
Link and Phelan also emphasize that stigma is a matter of power – certain groups in the society 
have the power to stigmatize. Stigma is also a matter of degree – there is a continuum between 
its existence and its absence. 
Corrigan1 focused on cognitive and behaviour features of mental illness. He proposed a model 
in which stigma was categorized either as public or self-stigma. 
Public stigma is defined as the reaction that the general population has to people with mental 
illness. Self-stigma is the prejudice which people with mental illness turn against themselves. 
In each of the categories, stigma is broken down into three elements: stereotypes (cognitive 
knowledge structures) prejudice (cognitive and emotional consequence of stereotypes) and 
discrimination (behavioural consequence of prejudice)18 . 
Thornicroft et al.19, elaborate on this framework, stating that stigma is composed of problems 
at three levels: knowledge, attitudes and behaviour. 
Mental health knowledge is also known in the literature as mental health literacy. Research by 
Jorm et al. in Australia has shown that better mental health literacy was correlated with better 
recognition of the features of mental illness, and potential better compliance with help seeking 
or medication and/or psychotherapy compliance.20 Nevertheless, according to Thornicroft19, 
despite improvement in mental health literacy, a series of government surveys in England 
between 1993 and 2003 revealed a mixed results regarding its impact on attitudes towards 
people with mental illness. Therefore, this author concludes that “an increase in knowledge 
about mental illness does not necessarily improve either attitudes or behaviour towards people 
with mental illness.” 
Negative attitudes, also known as prejudice, is the most studied component. According to 
Thornicroft, it can predict more strongly actual discrimination than do stereotypes. Attitudes 
have been widely researched. There are studies regarding both public, healthcare practitioners 
(and medical students) and caregivers. 
Thornicroft emphasizes the importance of studying actual behaviour, stressing that most of the 
studies have focused on attitudes towards hypothetical situations, rather than on actual 
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stigmatizing and discriminative behaviour. He therefore proposes a shift from research focused 
on stigma to research focused on discrimination.19  
1.1.5 Correlates and consequences  of stigma 
Stigma can have profound impact both at individuals with mental illness and their relatives.  
Rüsch et al.18 list four negative consequences of public stigma:  
 Everyday life discriminations encountered in interpersonal relations and depictions in 
media 
 Structural discrimination – inequity in the access to opportunities in private and public 
institutions.  
 Self-stigma (versus empowerment) 
 Fear of stigma as a barrier to use health services. 
About self-stigma and empowerment, Rüsch et al. comment, firstly, that self-stigma and 
empowerment are on the same continuum of self-esteem. They also remark that people may 
have different reactions to public stigma – while some people react with low self-esteem (being 
self-stigmatized), others might react with anger or indifference. They point out that a possible 
explanation for this resides both within group identification with public stigma and perceived 
legitimacy of it. They also point the issue of self-disclosure – a person who considers mental 
illness is a part of his/her identity will more likely reveal his/her condition to others. 
Secondly, they comment on the relationship between stigma and service use. People decrease 
usage of psychiatric services in order to overcome public stigma. This is supported by evidence 
showing associations of this lack of usage with negative reactions from family members and 
poorer social status. 
Lack of usage of psychiatric services is intrinsically linked to decreased treatment compliance 
and, therefore, poorer prognosis.21,22 
In a systematic review and meta-analysis conducted by Livingston and Boyd, internalized stigma 
has shown to be associated with variables at different domains.23 
In the psychosocial domain, stigma has been negatively associated with hope, self-esteem, 
empowerment/mastery, self-efficacy, quality of life and social support/integration, both at 
group and individual levels.23–25  
In the psychiatric domain, stigma has been positively associated with symptom severity and 
negatively with treatment adherence23. Still according to Livingston and Boyd, there are mixed 
results regarding association of stigma to diagnosis, illness duration, treatment setting and 
functioning: 
 Regarding diagnosis, only 10 of the 25 studies in Livingston and Boyd’s systematic 
review seemed to show a significant relationship between schizophrenia spectrum and 
stigma. From those, 3 have shown a positive association and 1 has shown a negative 
association.23 
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 Concerning illness duration, in the same review, from 14 studies found, 5 have shown a 
significant relationship. 4 of them seem to have found a negative association. 1 
documents a positive relationship.23 
 Regarding treatment setting, from 10 studies reviewed by the previews authors, only 3 
have found a significant relationship between hospital setting and stigma. From those, 
two showed a positive relationship.23 
 Still in the same systematic review, concerning functioning, from the eight studies, four 
of them have shown a negative relationship with internalized stigma23. We should also 
note Lundberg et al. found associations between more frequent rejection experiences and a  
lower degree of global functioning.26 
 Regarding setting of treatment, Angermeyer et al. 27 found that patients in old state 
psychiatric hospitals had less perceived and anticipated discrimination than patients 
living in the community. Chee et al. 28 found perceived stigma to be higher patients with 
schizophrenia living in the community but the opposite when patients had other 
diagnosis. 
 Regarding socio-demographic variables: from the 35 studies found by Livingston and 
Boyd, only 11 seemed to show a significant relationship between age and internalized 
stigma. From those, 4 have shown a positive relationship and 7 a negative relationship. 
From 38 studies comparing gender, male gender seemed to be significantly associated 
with stigma in 4 of the studies. In 3 of them female gender seemed to associate with 
more stigma. Employment status was studied in 14 articles. 4 of them seemed to show a 
significant association with being unemployed. Regarding marital status, only 1 of 11 
studies found seemed to show a significant association between being married and 
suffering more stigma. Another seemed to document a negative association between 
those variables.23 
1.2 STIGMA RESEARCH  
 
Wahl, in 1999, mentions four types of stigma research: 
 Research that involves self-reports from general public. 
 Research using vignettes or profiles of individuals and study participants’ ratings of 
people described.  
 Analogue behaviour studies, (“experimental studies”) in which people are led to believe 
they are dealing with a person with mental illness.  
 Research focused on mental health consumer, and his personal experiences of mental 
stigma. 
The latter type of research, according to Wahl, was, at the time, scarce. 29 
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The paradigm seemed to have gradually changed in the last decade and nowadays there is a 
relatively large number of instruments to measure personal experiences of mental stigma. 
1.2.1 Instruments to measure stigma - categories and criteria for psychometric properties 
In 2010, Brohan et al. 30, reviewed systematically 75 studies with instruments to measure 
personal experiences of mental stigma. The authors considered instruments to measure 
personal experiences of stigma in three categories: 
 Perceived stigma 
 Self-Stigma 
 Experience of stigma 
They describe the instruments and group them, according to those categories. They also 
reviewed those instruments, regarding quality criteria for health status questionnaires  
presented by Terwee et al.31 Those criteria are briefly described in Table 1. 
Table 1 - Criteria for quality of psychometric instruments (adapted from Brohan et al. and Terwee et al.) 30,31 
 
 
Brohan et al. found fourteen measures, used in the studies, which are listed in  
Table 2, and that were, thus, grouped in each of those categories. To these measures, we 
should add Maristan stigma scale (MSS). 
Content validity Clear description is provided of the measurement  aim, target 
population, concepts that the questionnaire is intended to measure, and 
investigators or experts involved in item selection 
Internal consistency Factor analysis performed on adequate sample size (minimum of 100 
subjects, 4 to 10 subjects per variable); Cronbach alpha between 0.70 
and 0.95 
Construct validity Specific hypotheses should be assessed (e.g. expected correlations 
between measures or expected differences in scores between “known” 
groups); at least 75% of the results are in correspondence with those 
hypotheses in a subgroup of at least 50 patients 
Test-retest reliability Intraclass correlation coefficients (ICC) or cohen’s Kappa ≥ 0.70 in a 
sample of at least 50 patients 
Floor-ceiling effects Are considered to be absent if less than 15% of respondents achieved 
the lowest or the highest possible score. 
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Table 2 - Scales assessing stigma experienced by people with mental illness (Adapted from Brohan et al.30) 
Scale Measures 
Perceived stigma 
Measures 
experience of 
stigma 
Measures self-
stigma 
Measures 
other 
PDD – Perceived 
devaluation and 
discrimination scale32 
Perceived 
discrimination 
(6 items) 
Perceived 
devaluation 
(6 items) 
No No No 
ISMI – Internalised 
Stigma of Mental 
Illness33 
No Discrimination 
experience 
(5 items) 
Alienation 
(6 items) 
Stereotype 
endorsement 
(7 items) 
Social 
withdrawal 
(6 items) 
Stigma 
resistance 
(5 items) 
SSMIS – Self-stigma of 
Mental Illness Scale34 
Stereotype 
awareness 
(10 items) 
No Stereotype 
agreement 
(10 items) 
Stereotype 
selfconcurrence 
(10 items) 
Self-esteem 
decrement 
(10 items) 
No 
CESQ – Consumer 
Experiences of Stigma 
Questionnaire29,35 
No Experiences of 
stigma (9 items) 
Experiences of 
discrimination 
(12 items) 
No No 
RES – Rejection 
Experiences Scale36 
No Rejection 
experiences 
(11 items) 
No No 
DSSS – Depression Self-
stigma Scale37 
Public stigma 
(4 items) 
Stigmatizing 
experiences 
(6 items) 
General 
selfstigma 
(9 items) 
Secrecy 
(9 items) 
Treatment 
stigma 
(4 items) 
SRER – Self Reported 
Experiences of 
Rejection38 
No Rejection 
experiences 
(12 items) 
No No 
SS – Stigma Scale39 No Discrimination 
(12 items) 
Disclosure 
(11 items) 
Positive 
aspects 
(5 items 
ISE – The Inventory of 
Stigmatising 
Experiences40 
Perceived 
stigma 
2 items 
Experienced 
stigma 
2 items 
Social 
withdrawal 
1 item 
Impact of 
stigma (5 
item) 
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SESQ – Self-esteem and 
Stigma Questionnaire41 
Feelings of 
stigmatisation 
(8 items) 
No No Self-esteem 
(6 items) 
HSS – Stigmatisation 
Scale42,43 
Perceived 
stigma 
(15 items) 
No No No 
MIDUS – MacArthur 
Foundation Midlife 
Development in the 
United States44 
No Major 
discrimination 
(11 items) 
Day to day 
discrimination 
(11 items) 
No No 
DISC – Discrimination 
and Stigma Scale45,46 
Anticipated 
discrimination 
(4-items) 
Experienced 
discrimination 
(32 items) 
No No 
EDS – Experiences of 
Discrimination Scale47 
No Has 
discrimination 
occurred 
(1 item) 
Specific settings 
of discrimination 
(8 items) 
No Stressfulness 
of 
discrimination 
in specific 
settings 
(8 items) 
Maristan stigma scale 
(MSS)48 
Health 
professionals (4 
items) 
 
No Self-Stigma 
(4-items) 
Informal 
Networks (11 
items) 
Socio-
institutional 
(12 items) 
1.2.2 Perceived stigma 
Perceived or felt stigma, according to Scambler et al49 original definition, refers principally to 
the fear of enacted stigma, but also encompasses a feeling of shame associated with the illness.  
Van Brakel et al50, however, remove the feeling of shame from that definition, considering 
research about perceived stigma as research in which “people with a (potentially) stigmatized 
health condition are interviewed about stigma and discrimination they fear or perceive to be 
present in the community or society”.  
Perceived stigma can refer both to what an individual thinks most people would believe 
towards a certain group of the society or what that individual thinks about him personally as a 
member of a stigmatized group.51 Components of perceived stigma reported in the literature as 
measurable variables  include stereotype awareness (perception by the individual of how 
individuals with mental illness are viewed by “most other people” in the society)1 and  personal 
expectations or fears of encountering stigma.  
Perceived stigma is addressed in the vast majority (79%) of the studies reported by Brohan et 
al. Seven measures were used in the literature to measure it: Perceived devaluation and 
discrimination scale (PDD)32, Self-stigma of Mental Illness Scale(SSMIS),34 The Inventory of Stigmatising 
Experiences (ISE) 40, Stigmatization Scale (HSS)42,43, Self-esteem and Stigma Questionnaire(SESQ) 41, 
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Depression Self-stigma Scale(DSSS) 37 and Discrimination and Stigma Scale(DISC)45,46. To those 
measures, we should add Maristan Stigma Scale (MSS).48 
PDD30,32 is the most commonly used scale. It totals 12 items - its two subscales measure 
perceived discrimination and perceived devaluation – a way of measuring stereotype 
awareness. Perceived stigma is also measured in 10 item stereotype awareness subscale in 
SSMIS34. HSS investigates perceptions of how the person feels they have been personally 
viewed or treated by the society. In 2 of its items, DISC addresses the expectation of being 
stigmatized in various aspects of life – a concept called anticipated discrimination. MSS48,52 
“health professionals” subscale measures patients’ perceived stigma regarding interactions 
with healthcare professionals. Therefore, in our opinion, although measuring interaction in a 
specific setting, it would fit in perceived stigma category. 
Regarding psychometric properties, all of the measures above mentioned have reports on 
content validity. On PDD, SESQ and DSS, it is not known if the target population was involved in 
selecting items in the scale. DSSS and SESQ meet aforementioned criteria of internal 
consistency. PDD, SSMIS, ISE and HSS, do not have reports of factor analysis, although 
Cronbach’s alphas meet defined criterion level. SSMIS and SESQ have studies in which test-
retest reliability is measured. MSS has been multiculturally tested, and its content validity was 
assessed. Cronbach alpha, internal consistency and test-retest reliability have been reported 
and meet criteria defined by Terwee et al. 
1.2.3 Self-Stigma 
As mentioned, self-stigma  is considered the internalization of the public stigma.34 For Corrigan 
et al, there are three components in self-stigma: 
 Cognitive response - negative belief about the self (e.g., character weakness, 
incompetence) 
 Affective response -  agreement with beliefs expressed by the public or the society and 
negative emotional reaction (e.g., low self-esteem, low self-efficacy)  
 Behaviour response to prejudice (e.g., failing to pursue work and housing 
opportunities)1,53  
Self-stigma is assessed by Internalised Stigma of Mental Illness(ISMI)33, Self-stigma of Mental 
Illness Scale (SSMIS)34, Depression Self-stigma Scale37 (DSSS), Stigma Scale39 (SS) and The 
Inventory of Stigmatising Experiences40(ISE). 
Alienation, stereotype endorsement and social withdrawal subscales in ISMI measure self-
stigma, which correspond to its affective, cognitive and behavioural dimensions54. SSMIS 
measures self-stigma through three sub-scales: stereotype agreement; stereotype self-
concurrence and self-esteem decrement30,34. SS has a “disclosure” subscale, which focus on the 
three dimensions already mentioned30,39. ISE contains one item on social withdrawal40. DSSS 
addresses self-stigma through two subscales – general self-stigma and secrecy: general self-
stigma measures personal stereotype awareness. The secrecy subscale is comparable to the 
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social withdrawal subscale in ISMI and disclosure scale in SS37. MSS48,52 has a 4 item subscale on 
self-stigma.  
According to Brohan, all the measures have reports on content validity. DSSS does not have 
disclosed data about target population and involvement in item selection. SSMIS and ISE’s 
Cronbach’s alpha values meet criteria by Terwee et al. but factor analysis is not reported. ISMI; 
DSSS and SS have both factor analysis and acceptable Cronbach alphas.  
ISMI, SSMIS and SS have their test-retest reliability measured, and meeting aforementioned 
criteria.  
1.2.4 Experience of stigma 
According to Brohan and van Brakel, experience of stigma is the  “experience of actual 
discrimination and/or participation restrictions on the part of the person affected”30,50. 
For the purpose of this definition, measuring experience of stigma can refer to measuring 
experiencing stigma in general or a report of experiences of stigma in specific situations or 
areas of life.30 
By measuring experience of stigma, one can, thus, assess direct effects of public stigma on the 
stigmatized individual.  
Measures of experience of stigma include ISMI, CESQ, SRES, DSSS, SRE, SS, ISE, MIDUS, DISC and 
EDS. 
CESQ will be addressed in a separate chapter. We should note it is the most used scale that 
addresses only experience of stigma.30  
ISMI’s discrimination experience subscale has 5 items. It addresses both perceived 
discrimination and general experiences of discrimination.54 
RES also measures self-stigma through both its subscales. However, it is developed only in 
Swedish. 
SS discrimination subscale has 12 items on general stigma experiences and specific 
experiences.39 ISE has two questions on general stigma experiences.40 DSSS contains 6 items 
about feelings of stigmatization after experiencing or disclosing depression.37 
DISC has 32 items addressing personal experiences of stigma in several areas of life.45 
MIDUS44 and EDS47 examine, besides experience of stigma, reasons for stigma. 
From the psychometric point of view, we should note that RSE, DSSS, SRE and EDS do not have 
studies that clarify target population involvement in selecting the items; EDS does not have 
reports on internal consistency. ISMI, DSSS, SS and MIDUS meet full criteria for internal 
consistency, according to Terwee et al.. DISC46 RES, SRE and IDE have been reported to have 
Cronbach’s alpha calculated with acceptable values, but have no factor analysis; only SS and 
ISMI measure test-retest reliability with acceptable values. 
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Other subscales identified in Brohan’s review measure additional elements of stigma, not 
covered by the perceived, experienced and self-stigma categories. Those include ISMI’s “stigma 
resistance”, SS’s “positive aspects”, “self-esteem” in SESQ, “treatment stigma” in DSSS and 
“stressfulness of stigma events” in EDS.  
Stigma resistance, positive aspects and self-esteem seem to be, according to Brohan et al, more 
related to self-estigma. Treatment stigma does not measure mental health stigma, but a related 
construct. “Stressfulness” is more related to discrimination, as it measures magnitude of 
experienced discrimination. 
MSS’s  informal networks subscale measures stigma perceived and experienced by the 
individual on the part of their informal network of care. It would be related with perceived and 
experience of stigma. Socio-institutional subscale measures aspects related to perception about 
mental health services organization. 
CESQ psychometric properties will be summarized in Section 1.3.2. 
1.2.5 Stigma studies in Portugal 
In Portugal, there have been few studies about stigma in mental illness.  
Most of the studies published so far are on the public stigma. 
In 2008 Loureiro et al. conducted a study about population’s attitudes and beliefs towards 
patients with mental illness in 834 individuals in the general population. They found out that 
public tolerability regarding people with mental illness is high. However, more authoritarian 
attitudes are related to  beliefs in  dangerousness and incurability.55 
Later, authors from the same working group translated and adapted a Portuguese version of 
the Survey of Mental Health Literacy in Young People, by Jorm et al. (QuALISMental)56 
In 2013 Loureiro, Jorm et al. conducted another study in which they assessed mental health 
literacy about depression in adolescents and young people. They applied the QuALISMental to 
4938 Portuguese young people between 14 and 24 years. They found out several deficits in the 
mental health literacy of respondents – failure to recognize depression on a vignette, and lack 
of knowledge about helpful treatments57 
Palha and colleagues in the NGO “Encontrar-se”58 have been active in this field of research and 
advocacy. In one of their studies they evaluated perceptions regarding people with mental 
illness in a sample of 285 university students. Students perceived people with schizophrenia as 
unpredictable, hard to talk, feeling different than the others and not improving without 
treatment. On the other hand, people with substance abuse were perceived as dangerous.59 
There is also work from Campos et al. evaluating an intervention to improve knowledge about 
mental illness in adolescents, with ages ranging from 15 to 18 years old. Quoting their results, 
“post intervention assessment showed a significant increase in the total score of the 
perceptions of knowledge; no significant differences in stigmatizing perceptions; and a 
significant decrease in help-seeking intentions when facing a mental health problem, although 
most participants have come to consider different types of help”.60 
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More recently, Campos et al. evaluated knowledge about mental illness in younger adolescents, 
aged 12 to 14 years old before and after an intervention. Results showed a reduction in 
stereotypes and increase in knowledge about mental illness, as well as better recognition of 
mental health conditions and improved help-seeking behaviour, with the intervention.61 
Chambers, Botelho et al. applied the Community Attitudes towards the Mentally Ill (CAMI) scale 
to 810 nurses working in psychiatric wards and units and community facilities in a multicentre 
study with participations from Finland, Lithuania, Ireland, Italy and Portugal. One hundred and 
twenty four of them were from Portugal. They found that Portuguese nurses had more positive 
attitudes towards mentally ill than nurses from the other countries studied. Positive attitudes 
are associated with being female and having a senior position.62 
There is also work from Gonçalves Pereira et al., regarding stigma in 108 caregivers. They  used 
the stigma subscale of the Szmukler et al’s Experience of Caregiving Inventory as part of 
comprehensive assessments to explore the consequences of caregiving. Sense of stigma was 
one of the covariates for the negative impact of caregiving in a regression model.63 
Personal stigma has been increasingly studied over the last few years. 
There is record of an authorized translation of ISMI64, but, to best of our knowledge, there are 
no psychometric studies about it. 
The Maristán stigma scale, previously mentioned in section 1.2.1, has been translated to 
Portuguese. It was validated in using a sample collected in several countries including Portugal. 
Items of the scale were developed through focus groups. Factor analysis was made and test-
retest reliability was assessed. The Portuguese subsample was composed of 20 patients with 
schizophrenia or a related psychosis (out of 164 on the global sample).  48 
We should also note a study by Sousa et al.65 In that study, which aimed to study relationship 
between self-stigma and recovery potential, the authors applied a Portuguese authorized 
translation of ISMI, as well as the Recovery Assessment Scale, to 50 outpatients with 
schizophrenia. They found that participants had moderate scores in discrimination experiences 
subscale of ISMI. They also found a moderate negative correlation between the stereotype 
endorsement subscale of ISMI and recovery potential in schizophrenia. 
To the best of our knowledge, there are no published Portuguese studies specifically on what 
has been defined, strictly speaking, as the experience of stigma. 
CESQ, the most studied scale that measures experience of stigma,66 has an authorized 
European Portuguese translation, but its psychometric properties had not been documented 
until now. 
 
1.3 CONSUMER EXPERIENCES OF STIGMA QUESTIONNAIRE (CESQ) 
 
The CESQ was developed in 1999 by Wahl 29, with the collaboration of the National Alliance for 
Mentally Ill (NAMI). 
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Its development was based on the fact that most of the research on stigma until then seldom 
focused on the real life experience of mental health consumer. 
The questionnaire is available as a self-reporting tool, but has also been administered in face to 
face interviews.35 
Dickerson et al. modified the questionnaire by replacing the term “consumer” in the text by 
“person who has mental illness”, person who has a psychiatric disorder” or “person who uses 
psychiatric services”.35  Sample items from versions developed by Wahl and by Dickerson et al. 
are available, respectively, in Annexes 2 and 3. 
The questionnaire has two sections. The “stigma” section and the discrimination section 
include, respectively, nine and twelve items.29,35  
It was  translated into Chinese67, and Polish68–70.  Psychometric data were not reported for 
Chinese translation. 
There is also a Portuguese  authorized translation of CESQ, with its corresponding 
backtranslation71 , which remained unpublished until now.  
1.3.1 Research involving CESQ 
In Wahl’s original study, a postal survey which had 1301 respondents, obtained from the NAMI 
mailing list. Respondents had been diagnosed mainly with bipolar disorder (25%) but also with 
schizophrenia (19%) and major depression (15%).   
Most commonly reported stigma experiences included witnessing stigmatizing comments about 
mental illness (50% often or very often), encountering hurtful or offensive media portrayals of 
it (47% often or very often), or being treated as less competent by others once their illness had 
been disclosed (36% often or very often). Twenty six percent of the respondents often had the 
experience of sometimes being shunned or avoided. Sixteen percent reported seldom or never 
receiving support from friends. More than half (55%) of them said they worried that others 
would view them as service users. 
Discrimination experiences, such as being turned down for a job, were less reported: one in 
three respondents reported that they had been turned down a job, and 28% found work 
environment unfriendly. 
Wahl’s study has a few limitations. First, it is based in a sample of patients affiliated with an 
advocacy organization, and who chose to respond to a stigma questionnaire.  Wahl himself 
questions if it represents the typical mental health service user. Secondly, it is based in a 
heterogeneous sample, which includes both patients with severe mental illness and patients 
with common mental illness. Thirdly, it does not establish a correlation between stigma and 
other variables such as patients socio-demographic characteristics, illness severity, gender, 
mood-related variables, or illness insight29,35. 
Dickerson et al.35, in 2002, applied the CESQ to 74 outpatients with schizophrenia. They 
administered CESQ in face-to-face interview. They assessed symptom severity, quality of life 
and social functioning, socioeconomic status, gender, mental illness attribution and depression. 
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Item to scale correlations were calculated, regarding stigma and discrimination section of CESQ. 
All of the items in the stigma section correlated within acceptable limits with total score for 
that section. Only 6 of 12 items in the discrimination section correlated within acceptable limits 
with total score for discrimination. 
In their sample, Dickerson et al. found that the ranking of responses was similar to the one that 
had been found with the NAMI-affiliated sample studied by Wahl. However, average ratings of 
CESQ items were higher in Wahl’s sample, meaning patients affiliated with NAMI would more 
frequently report stigma experiences. 
Surprisingly, they did not find correlations between stigma and psychiatric symptoms, 
depression, subjective satisfaction with living situation or subjective satisfaction with safety.  
There was an inverse moderate correlation between several subjective variables from the 
quality of life scale and the stigma total score: subjective satisfaction with daily activities, 
subjective satisfaction with family contact, subjective satisfaction with finances, and subjective 
satisfaction with health. The variable measuring “Perceived Adequacy of Finances to Meet Daily 
Needs” from the Quality of Life Interview was moderately and inversely correlated with total 
stigma score. In a multiple regression analysis model on the stigma total score, where the 
former variables were entered, only the perceived adequacy of finances remain significant in 
the equation. 
Socioeconomic status based on parental occupation was moderately correlated with 
discrimination total, and remained significant in univariate comparisons. 
Bagley and King did an exploratory analysis on three stigma scales, including CESQ. They 
analysed 13 of the items for scalability. Criteria for scalability of the item were: correlation of 
0,4 or greater with the scale total and  the resulting scale having an alpha value of at least 
0,80.42 They found that only 7 of the 13 items did fulfil criteria for scalability. The study does 
not address the fact that there are two subscales in CESQ, and authors do not calculate alpha 
value for both subscales nor does a factor analysis. 
Switaj et al.68, in 2009, applied stigma section of CESQ to 153 inpatient and outpatient patients 
with schizophrenia, diagnosed according to ICD-10 criteria, aged between 18 and 65 and that 
were not dependent on drugs of alcohol. They also applied Satisfaction with life domains (SLDS) 
scale in order to assess subjective quality of life, Global Assessment of Functioning (GAF) for 
global functioning, Frankfurter Befindlichkeits-Skala (FBS) and Paranoid-Depresivitäts-Skala (PD-
S) to assess patient rated severity of symptoms and Clinician Assessment of Schizophrenic 
Syndromes (CASS) in order to measure severity of psychiatric symptoms. 
Regarding CESQ, they found out that up to eighty-six percent of the patients avoided to disclose 
the fact that they are receiving psychiatric treatment to people outside the family. Forty to 
seventy percent of the patients reported, at least sometimes, the following experiences: being 
avoided by others, treated as less competent, advised to lower one’s expectations in life, 
having worried about being viewed unfavourably by others, hearing negative comments about 
the mentally ill or encountering offensive media depictions of mental illness. The questionnaire 
has shown good internal consistency. (Cronbach’s alpha = 0.79) 
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Regarding relationships between clinical and social-demographic characteristics and stigma, 
they found a negative association with subjective quality of life, which matches previously 
described data. 
They also found, through stepwise regression multiple analysis of socio-demographic and 
clinical characteristics and stigma that patients who became ill at a younger age felt more 
stigmatized.  
There was a positive correlation between stigma and patient rated symptoms, in both Paranoid 
and Depressive subscales of PD-S.  
They found no significant associations, between the level of stigmatization experienced by the 
participants and age, sex, education, marital status, housing status, current employment or 
number of years in employment, type of psychiatric setting, duration of illness, number of 
involuntary hospitalizations, medication side effects, social functioning and overall severity of 
clinician rating symptoms. This is consistent with results reported by Dickerson et al. 
In a new study (2012), Switaj and colleagues69 also applied CESQ to 442 patients, treated in 
various psychiatric care facilities in Warsaw. 63% of them were diagnosed with psychotic 
disorders, and 14% of them with affective disorders. In accordance with the previous study, a 
majority of patients reported having often or very often avoided telling others about their 
mental health problems. More than a third indicated having often or very often heard others 
make unfavourable or offensive statements about people with mental illness, worried about 
being viewed unfavourably by others, and been treated as less competent. Nevertheless, it 
should be noted that only a small fraction of subjects believed that people who knew about 
their illness seldom or never treated them fairly, and that their friends were not understanding 
and supporting. 
Regarding discrimination experiences, they were less reported, in parallel with what happened 
in previous studies29,35 : Just above half of those interviewed said that in their written 
applications for jobs, housing, school, or licenses of all types they often or very often avoided 
mentioning that they are in psychiatric treatment. Approximately 1 in 4 respondents said that 
their colleagues or superiors at work who knew about their mental health problems seldom or 
never were supportive and accommodating, and about 1 in 5 thought that representatives of 
the justice system had not treated them with consideration and kindness. Slightly less than 10% 
reported that they were often or very often turned down for a job. 
In 2013, the same group conducted a secondary analysis of the previous described samples, 
performing a factor analysis in order to assess construct validity of stigma section of the scale70.  
They decided not to use the discrimination section of CESQ. This decision is due to the fact that 
in their sample, the discrimination section was proved to have unsatisfactory internal 
consistency (Cronbach’s α = 0,63), which is corroborated by work by Solomon et al72 and to the 
fact that as many as 7 items in the discrimination section were only endorsed by a marginal 
proportion of respondents. 
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They selected only cases which completed the full stigma section –373 in their 2012 study 
(sample one) and 136 sample of the 2009 study (sample two). 
Regarding data analysis, they started to randomly split sample one in two demographically and 
clinically equivalent subsamples.  
Internal consistency of the 9-item stigma subscale was not acceptable regarding inter-item 
correlation (0,302 in sample one and 0,282 on sample two), although Cronbach alpha has 
acceptable in both samples. (0,799 and 0,788 respectively).  
Two of the items in the Stigma subscale were found to be psychometrically poor in exploratory 
factor analysis and were, thus, discarded. The remaining 7 items model parameters of fit were 
in the acceptable ranges in confirmatory factor analysis. 
Concurrent validity was assessed using SLDS (quality of life), PD-S, FBS (patient reported 
symptoms), GAF (global functioning) and CASS (clinician-rated symptoms). Pearson correlations 
of the 9 item scale and 7-item scale both seemed to show moderate correlations with 
satisfaction with life domains and patient reported symptoms, but not with global functioning 
or clinician rated symptoms. 
Lv et al.73 applied CESQ to measure discrimination and ISMI, to measure self-stigma. They found 
the most scored items were “Have you avoided telling others outside your immediate family 
that you have received psychiatric treatment” and “Were your friends understanding and 
supportive when they learned you have received psychiatric treatment?” They have found that 
self-stigma in all its domains (alienation, sterotype endorsement, perceived discrimination and 
social withdraw) correlated with stigma experiences and total stigma score, but did not 
correlate with discrimination experiences, except for stereotype endorsement domain. 
1.3.2 Psychometric properties 
Summarizing what was previously mentioned, CESQ is the most studied scale that only 
measures experience of stigma.30 
Psychometric properties and compliance with general criteria defined by Terwee at al. for 
measurement properties of health status questionnaires are as follows: 
 Content validity was reported by Wahl et al.29, and meets Terwee criteria. 
 Criterion validity – there are no studies measuring CESQ against other stigma measures 
in the literature. 
 Construct validity – it has been established by Dickerson et al. and replicated by Switaj 
et al., regarding the stigma section. There were no correlations found of the stigma 
subsection with psychiatric symptoms or general functioning, but there was a negative 
association between stigma and age of becoming ill68 and stigma and quality of 
life35,68,70. 
 Internal consistency – Cronbach’s alpha was assessed in stigma subscale (α=0,79)68,70 In 
discrimination subscale, alpha reported is 0.6370. Factor analysis was done only in 
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stigma subscale.70 There are no studies, to the best of our knowledge, reporting 
assessment of alpha for the whole scale. 
 Floor/ ceiling effects – CESQ fails the criteria in all of the studies mentioned.29,30,35,68–70 
 Test retest reliability has not been reported in the literature. 
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2 ORIGINAL STUDY 
2.1 AIMS 
 
To explore the experience of stigma in a Portuguese sample of people with severe mental 
illness. 
To contribute to the assessment of psychometric properties of Consumer Experiences of Stigma 
Questionnaire29, and to the validation of its Portuguese translation. 
 
2.2 METHODS 
 
2.2.1 Study design 
Cross-sectional, descriptive and analytic study. 
2.2.2 Samples 
 
Our global sample was composed of three convenience, non-randomized subsamples of 
patients with severe mental illness. 
The first one (ARIA sample) consisted of 60 patients  from Associação de Reabilitação e 
Integração Ajuda (ARIA)1, an NGO from the Lisbon area  that provides services in integration 
and rehabilitation to people with severe mental illness..74 Its areas of intervention are 
vocational training programs and employment. ARIA runs a social firm with protected 
employment, two residential units and four socioocupational forums. 
Subjects were referred by mental health professionals from ARIA. 
From those 60 patients, 49 accepted to participate in the studies. 
Patients came from several facilities in ARIA, as follows: 29 (59.2%) came from socio-
occupational forums, 5 (10.2%) came from social action forum 7 (14.3%) from professional 
qualification and training facility, and 8 (16.3%) from residential units. 
The second subsample (Idanha sample) was composed of 43 inpatients from acute and chronic  
psychiatric units from Casa de Saúde da Idanha, Sisters Hospitallers75, a psychiatric clinic located 
in Belas, near Lisbon. Forty two accepted to participate: nine patients (21.4%) from Acute 
Inpatient Unit and 33 patients from units 3 and 4, which houses prolonged evolution patients. 
The third sample (FAPS sample) was drawn from patients participating in the FAPS study, a 
study of families of people with psychosis63,76, and was composed of 32 outpatients. 
                                                          
1 http://www.ARIA.com.pt 
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2.2.3 Ethical issues 
 
Patients gave their written informed consent to participation in the study.  
Permission was obtained for this study, from the ARIA Board of Directors and from the Board of 
directors and ethics committee in Casa de Saúde da Idanha.  Ethics committees had also 
authorized data collection for the FAPS study. 
Confidentiality was fully assured. All the information was processed anonymously and 
demographic and clinical data were stored separately from identification data, only accessible 
to the investigator. 
 
2.2.3.1 Inclusion and exclusion criteria 
Inclusion criteria were: 
 Patients with history, according to  International Classification of Diseases 10 (ICD 10)77 
of 
o Schizophrenia, (F20) 
o Schizoaffective disorder (F25) 
o Delusional disorder (F22) 
o Bipolar disorder, manic episode with psychotic symptoms (  F 31.2) 
o Bipolar disorder, depressive episode with psychotic symptoms (F31.5) 
o or Major depressive disorder with psychotic symptoms (F32.3) 
 Patients should be clinically stable (in order to be able to stand for evaluation). 
 
ICD-10 definitions of the disorders are listed in Annex 1. 
 
2.2.4 Instruments 
 
2.2.4.1 Demographic and Clinical Data 
 
Demographic data collected was: 
 age, 
 gender, 
 marital status,  
 current living situation 
 current employment status 
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Clinical data collected was: 
 psychiatric diagnosis 
 age at onset of illness 
 duration of illness  
 
Clinical data was collected by direct reporting of patients and completed by looking through clinical files. 
2.2.4.2 Consumer Experiences of Stigma Questionnaire (CESQ) 
The Portuguese version of CESQ adopts the Dickerson et al.35 adaptation of the Wahl’s original 
scale.29 Its translation was made  by Gonçalves-Pereira,71  as authorized by the original author. 
Otto Wahl also checked a back-translation by a professional translator who was an English 
native, fluent in Portuguese and acquainted with the mental health field of research. This 
translation is available upon request. 
For the present study, the Portuguese version of CESQ was discussed with mental health 
professionals from the institutions where the samples were collected, as for pertinence and 
phrasing of questions and adaptation to Portuguese reality. 
Mental health professionals had the unanimous opinion that item “Have you been excluded 
from volunteer or social activities in mental health field when it was known you had received 
psychiatric treatment?” was not applicable to the Portuguese reality. 
Moreover, a pilot study was run and we found that participants did not respond to that item, 
and even found it confusing. Thus, we did not consider it for this study. 
  
The  Portuguese translation of CESQ is suitable both for face-to-face or self-report 
administration. It has two subsections: 
 Stigma subscale – nine items  - as detailed in Results (Table 6) - about people’s 
interpersonal experiences as “consumers”. Those questions are about topics such as 
specific treatment by others, negative things seen and fears of behaviours related to 
disclosure of status by consumers. Each experience is rated on a 5-point Likert scale, 
ranging from “never” to “very often”. Participants had the option to state that the item 
did not apply. 
 Discrimination subscale – eleven items  - as detailed in Results (Table 7) which intend to 
explore experienced discrimination in activities such as getting a renting an apartment, 
applying for a job, volunteering, or obtaining a license, as well as an item concerning 
avoidance of disclosure of a service user’s status in applications. This section is also 
rated on a 5-point Likert scale, ranging from “never” to “very often”. Participants also 
had the option to state that the item did not apply. 
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Items were  scored 1 (never) to 5 (very often), with the exception of Items “Were friends 
understanding and supportive after learning that you receive psychiatric treatment?”, Have you 
been treated fairly by others who knew you received psychiatric treatment ?, “Have co-workers 
and supervisors at work been supportive and accommodating when they learned that you 
received psychiatric treatment?” and “Have you been treated with kindness and sympathy by 
law enforcement officers when they learned you had received psychiatric treatment?” which  
were reversely coded. We followed the principle, by Dickerson et al. of using a “Does not apply” 
option. When “does not apply was chosen, responses were scored as “0”, for the purpose of 
computing the scores.35,68 Scores of the sections were computed adding the values for each 
item.   .  
In order to assess test-retest reliability, the scale was given to the patients in the ARIA 
subsample and its administration repeated within one to three weeks in all of those 
participants who accepted to do so. 
2.2.4.1 Global Assessment of Functioning (GAF) 
 
The Global Assessment of Functioning scale has its roots in the Health Sickness Rating Scale (HSRS), 
published in 1962. Studies regarding HSRS originated Global Assessment Scale (GAS). Further 
development of GAS led to GAF. 
GAF  was implemented in 1987, in the Axis V of the Diagnostic and Statistical Manual 4th edition78. It 
measures individual functioning, regarding psychological, social and occupational domains. It is a 
numerical scale. It is rated from 1 to 100, thus there are 100 scoring possibilities. The scale is divided in 
intervals, or sections, each one with ten points. 
There are a few limitations regarding validity of GAF, mostly regarding its scoring, intervals and anchor 
points79.However,  it has been shown to have good inter-rater reliability80 and still remains as the most 
used measure of functioning.81  
GAF score was assessed in Idanha and FAPS subsamples. 
 
2.2.5 Statistical Analysis 
 
The data collected for the present study was analysed with the employment of several statistical 
techniques and methodologies. We present an exploratory data analysis where descriptive statistics, 
parametric (t-test, one-way ANOVA, chi-square test) and non-parametric (Mann-Whitney, Kruskal-
Wallis) tests were used as required. Each statistical test assumptions were verified and the results and 
outcomes as well as several graphs are presented in the Annexes. Continuous variables were also 
assessed for normality, using either the Kolmogorov-Smirnov test or the Shapiro-Wilk test (the latter 
used when the size of the sample being analysed was less than 50). 
Patients’ characteristics are presented as frequencies and percentages for categorical data, and as mean 
or median, standard deviation (SD), range and minimum/maximum values for continuous variables. The 
95% confidence intervals (CI) for the mean values were calculated and presented whenever appropriate.   
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The scale was tested for internal consistency using Cronbach’s alpha and exploratory factor analysis. The  
ideal value for Cronbach’s alpha was considered to be at least 0.7.82 
Principal component analysis was primarily used to conduct an exploratory factor analysis to inspect the 
structure of the CESQ questionnaire by examining its components (afterwards called factors) and 
investigate whether the presence of the two domains (stigma and discrimination) could be identified. 
The aim of factor analysis in the present context was to determine empirically whether the participants’ 
responses to the stigma domain questions were more similar to each other than their responses to the 
discrimination items, and vice versa. It is, consequently, an exploratory factor analysis on the CESQ 
scores, as the objective is to seek to describe, and summarize, data by grouping together variables/items 
that are correlated. 
In order to verify the appropriateness of the factor analysis, three techniques were used for the 
assessment of the psychometric adequacy of the correlation matrix. They were the Bartlett’s test of 
sphericity, evaluating the hypothesis that the correlation matrix is an identity matrix, that is, that there 
is no correlation amongst the items; rejection of this hypothesis suggests that the data are appropriate 
for the factor analysis procedure. The second technique was the inspection of the off-diagonal elements 
of the anti-image correlation matrix, this contains the negatives of the partial correlation between pairs 
of variables with effects of other variables removed, enabling the quantification of individual measures 
of sampling adequacy (MSA) and to conclude that the correlation matrix is factorable whenever the 
absolute values of most of those elements are small (see Tabachnick and Fidell83 for more details). 
The Kaiser-Meyer-Olkin (KMO) statistic was the third technique to be used. This corresponds to an 
overall MSA that varies between 0 and 1. According to Tabachnick and Fidell83, values of 0.60 and above 
are required for a good factor analysis. 
Sample size must be sufficient to cope with the rigorous of factor analysis. However, there is much 
debate about what the minimum limit should be (see Mayers82 for a discussion). With this data a ratio of 
6:1 was obtained and, as it corresponds to a reasonable value, the criterion was met. 
Two factors were chosen because there was interest in verifying whether the questions in this 
questionnaire showed evidence of the presence of the two latent factors (i.e. stigma and 
discrimination). 
The varimax rotation technique with Kaiser normalization was employed. It was postulated that factor 
loadings presented should be greater than 0.40. In case of several loadings greater than 0.40 for a 
particular item, that item should be used on the factor with the highest loading. 
Intraclass correlation coefficients (ICC) were calculated, using a two-way mixed effects model, where 
people effects are random and measures effects are fixed.84 
The 95% confidence intervals for the Cronbach alphas were obtained through the “psychometric” 
package of the R statistical software.85,86. 
All other analysis were performed through IBM Statistical Package for Social Sciences (SPSS) version 
22.87  
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3 RESULTS 
3.1 SUBJECTS 
 
Initially 135 participants were screened as eligible in a sample collected on each of the three 
subsamples- (60 in ARIA, 43 in Idanha and 32 in FAPS). 
From those, an overall total of 122 participants (49 from ARIA, 42 from Idanha and 31 from FAPS) 
accepted to participate in the study. 
3.2 SOCIO-DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PARTICIPANTS 
Frequencies and percentages for the several variables characterising the participants are displayed in 
Table 3. 
Table 3 Socio-demographic characteristics of the participants 
n  122 
Gender Female (%) 54 (44.3%) 
Male (%) 68 (55.7%) 
Age 
(years) 
Mean (95% CI): 44.9 (42.54,47.26) 
SD: 13.004 
Range 18-96 
Marital status Single (%) 98 (80.3%) 
Married / Living together (%) 9 (7.4%) 
Divorced / Widow (%) 15 (12.3%) 
Living status 
 
Living in the community alone (%) 18 (14.9%) 
Living in the community with family support (%) 63 (52.1%) 
Homeless (%) 1 (0.8%) 
Living in an institution (%) 39 (32.2%) 
Occupational status Unemployed / Retired (%) 99 (82.5%) 
Employed / In professional training (%) 21 (17.5%) 
Local ARIA 
Idanha 
FAPS 
60 (44.8%) 
43 (32.1%) 
31 (23.1%) 
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From the overall total of the 122 participants, only five (4.2%) were more than 65 years old. The gender 
proportion was balanced. 
The majority of the participants (80.3%) were single (never married), and eighty two (67.8%) were living 
in the community, while thirty nine (32.2%) were living in an institution. 
The three subsamples were significantly different regarding several of the variables. Concerning gender 
(p<0.001) most participants in Aria and FAPS were males (73.5% and 83.9%, respectively) whereas in 
Idanha women participants were 85.7% of that subsample (see Table 9 in Annex 5). We compared two 
categories of living status, i.e. living in the community or living in an institution. The majority of patients 
in ARIA (89.6%) and in FAPS subsample (100%) were living in the community whereas the highest 
percentage of patients from Idanha (81%) were living in an institution (p<0.001). However, there was no 
evidence of association (p=0.156) between being part of one of either of the three subsamples and the 
occupational status (unemployed/retired and employed/professional training). 
Since the age of the participants registered in Idanha was not normally distributed (p=0.003) (Figure 1) 
the non-parametric Kruskal-Wallis was employed to test whether the participants’ age median values 
were equal on the three locations. It was found that the median ages differed on the three locations 
(p<0.001). In the Idanha subsample, participants tended to be older. (Figure 2) 
Detailed socio demographic data regarding the samples is showed in Table 9 (Annex 5). 
Clinical characteristics of the participants are listed in Table 4. They are detailed, concerning each of the 
subsamples in Table 10 (Annex 5) 
We were only able to collect data on diagnosis from 87 participants. Schizophrenia (ICD 10 F20) was the 
most predominant diagnosis, accounting for 67.8% of the total cases. 
The non-parametric Mann-Whitney test was employed as the reported age of diagnosis does not seem 
to follow a Normal distribution (Shapiro-Wilk, p<0.001 and p=0.007 for the ARIA and IDANHA 
subsamples, respectively). (see Figure 3)  No significant differences were found (Mann-Whitney test, 
p=0.211) on the median values of age of diagnosis on the two subsamples (see Figure 4 for box plot.) 
 
Table 4 - Clinical characteristics of the sample 
  n % 
Diagnosis 
Schizophrenia (F20.0) 59 67,8 
Bipolar disorder (F31) 12 13,8 
Schizoaffective disorder (F25) 8 9,2 
Depression (F32.3) 6 6,9 
Delusional disorder (F22) 2 2,3 
 Total for diagnosis 87 100 
Reported age at onset of illness 
(years) 
Mean  23.95 
SD  8.540 
Range 11-57 
Reported duration of illness 
(years) 
Mean: 21,00 
SD: 13.116 
Range 2-77 
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Global Assessment of 
Functioning  (GAF) Score 
Mean 42.85 
SD 14,820 
Range 21-75 
Total n for GAF score 73 
 
The participants’ duration of illness followed a Normal distribution on the three subsamples (Shapiro-
Wilk tests with p=0.071, p=0.052 and p=0.164, for ARIA, IDANHA and FAPS, respectively). The variances 
of the illness durations could also be considered equal (Levene test, p=0.172). Consequently, a one-way 
ANOVA procedure was used to compare the mean values of the illness duration on the three locations. 
The null hypothesis of equality of mean values was rejected (p<0.001). Through multiple comparisons 
technique, namely Tukey HSD and Sheffe, it was found that the illness duration of participants from 
IDANHA differed from the other two subsamples (p<0.001). There was no reason to believe that 
participants in ARIA and FAPS had different mean values of illness duration (Tukey HSD test, p=0.709). 
Please also refer to page 56. 
 
3.3 RESPONSES TO THE CESQ STIGMA SECTION  
 
Responses to the stigma section are listed in Table 6.   
We will follow, after Wahl29 and Switaj68, the principle that only experiences reported at least 
sometimes by all participants are worth noting in the description of results. 
Being in situations where one hears others say unfavourable or offensive things about persons and their 
psychiatric disorders is the most reported negative experience. A majority (64.5%) of the participants 
say they experienced it at least sometimes, while  28.9% say they have experienced at least often. 
More than 62% of the respondents say they are at least sometimes worried that others will view them 
unfavourably because they received psychiatric treatment, as 33.9% report it happened often or very 
often. 
Avoiding telling others outside the family they have received psychiatric treatment is the third most 
reported negative experience 52.5% report it at least sometimes and 28% at least often. 
Fifty percent of the participants feels sometimes, often or very often treated by others as less 
competent, and people report that, at least sometimes, they have been told to lower expectations in 
life. Forty seven percent of the participants reported that, at least sometimes, have been shunned or 
avoided by others. Forty six percent report that, at least sometimes, they see depictions of mental 
illness in media they find hurtful or offensive. 
Positive experiences are also reported with high frequency: Seventy eight percent of the participants 
consider that, at least sometimes, friends were understanding and supportive after learning they had 
received psychiatric treatment, and 77.3% of the participants feel at least sometimes treated fairly by 
others. 
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3.4 RESPONSES TO THE CESQ DISCRIMINATION SECTION 
Responses to discrimination subscale items are listed in Table 7. 
Discrimination experience frequencies were significantly lower than stigma experiences.  
Nevertheless, 43.5% of the respondents state that, at least sometimes, have avoided indicating on 
written application that they received psychiatric treatment for fear that information would be used 
against them. 
Forty one percent of the respondents report that they never or seldom have been treated with kindness 
and sympathy by law enforcement officers when they learned they had received psychiatric treatment. 
Thirty nine percent of the participants say that, at least sometimes, they have been turned down for a 
job, for which they were qualified, when it was learned they had been receiving psychiatric treatment. 
 
3.5 COMPUTED SCORES AND EXPLORATORY ANALYSIS 
Histogram of frequencies of computed scores regarding Stigma Section, Discrimination Section and Total 
of the scale scores are shown in Figure 18, Figure 20, and Figure 22, in Annex 4. 
Table 5 displays descriptive statistics for scores of the scale total (CESQ Total score) and Stigma and 
Discrimination subscales. Box plots for CESQ total score and gender, occupational status, 
institutionalization and marital status are shown in Figure 6, Figure 7, Figure 8 and Figure 9. Figure 10, 
Figure 11, Figure 12 and Figure 13 show Stigma score and each of the latter variables. Figure 14, Figure 
15, Figure 16 and Figure 17 show discrimination score and gender, occupational, institutionalization and 
marital status. 
Both CESQ total score, stigma and the discrimination scores followed a Normal distribution 
(Kolmogorov-Smirnov tests with p=0.200, p=0.098 and p=0.200, respectively). QQ plots of CESQ Total 
score are shown, respectively in Figure 19, Figure 21 and Figure 23. 
 
Table 5 – Descriptive statistics -  Total scores, stigma and discrimination scores 
  CESQ Total score Stigma score Discrimination 
Score 
Gender 
mean (SD) 
Female  37.8 (12.30) 23.4 (7.39) 14.2 (7.65) 
Male  40.5(11.54) 21.9 (6.42) 18.6 (7.06) 
Occupational 
status 
mean (SD) 
Unemployed / Retired 
(%) 
39.8 (12.24) 23.1 (6.96) 16.75 (7.91) 
Employed / In 
professional training (%) 
37.0 (10.67) 21.0 (6.04) 16.0 (6.54) 
Living status 
mean (SD) 
Living in the community 39,9 (11.78) 22.1 (6.25) 17.8 (7.08) 
Living in an institution 37.9 (13.54) 23.7 (8.03) 14.1 (8.27) 
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Marital status 
mean (SD) 
Single 39.8 (1.19) 22.8 (0.68) 17.0 (0.76) 
Married / Living 
together 
36.2 (5.52) 22.2 (3.53) 14.0 (3.38) 
Divorced / Widow 37.0 (2.55) 21.2 (1.59) 15.8 (1.62) 
 
29 
 
Table 6- Responses to stigma section 
  Never Seldom Sometimes Often Very often 
N % N % N % N % N % 
Have you avoided telling others outsider of your immediate family 
that you have received psychiatric treatment? 
38 32,2% 18 15,3% 29 24,6% 16 13,6% 17 14,4% 
Have you been treated as less competent by others when they 
learned you had received psychiatric treatment? 
36 30,5% 23 19,5% 35 29,7% 15 12,7% 9 7,6% 
Were friends understanding and supportive after learning that you 
receive psychiatric treatment? 
12 10,1% 14 11,8% 36 30,3% 38 31,9% 19 16,0% 
Have you been shunned or avoided by others when they learned 
you received psychiatric treatment? 
43 35,8% 21 17,5% 36 30,0% 14 11,7% 6 5,0% 
Have you been in situations where you heard others say 
unfavourable or offensive things about persons and their 
psychiatric disorders? 
30 24,8% 13 10,7% 43 35,5% 21 17,4% 14 11,6% 
Have you been advised to lower your expectations for 
accomplishments in life because you receive psychiatric 
treatment? 
47 39,5% 21 17,6% 30 25,2% 15 12,6% 6 5,0% 
Have you been treated fairly by others who knew you received 
psychiatric treatment ? 
13 10,9% 14 11,8% 27 22,7% 44 37,0% 21 17,6% 
Have you seen or read things in mass media about persons 
receiving psychiatric treatment and their psychiatric disorders 
which you found hurtful or offensive? 
45 37,5% 20 16,7% 37 30,8% 9 7,5% 9 7,5% 
Have you worried that others will view you unfavourably because 
you received psychiatric treatment? 
25 20,7% 20 16,5% 35 28,9% 20 16,5% 21 17,4% 
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Table 7 - Responses to discrimination section 
  
Never Seldom Sometimes Often Very often 
N % N % N % N % N % 
Have you been turned down for a job, for which you were qualified, 
when it was learned you received psychiatric treatment? 54 50,0% 12 11,1% 23 21,3% 12 11,1% 7 6,5% 
Have you been denied psychiatric treatment because your health 
insurance or healthcare system was insufficient for you to pay the 
cost? 
87 85,3% 4 3,9% 7 6,9% 1 1,0% 3 2,9% 
Have you had difficulty renting an apartment or finding other 
housing when your psychiatric disorder was known? 70 78,7% 6 6,7% 8 9,0% 1 1,1% 4 4,5% 
Have you been denied educational opportunities when it was 
learned that you received psychiatric treatment? 68 66,7% 12 11,8% 16 15,7% 1 1,0% 5 4,9% 
Have you been excluded from volunteer or social activities outside 
mental health field when it was known you had received psychiatric 
treatment? 
71 69,6% 16 15,7% 12 11,8% 1 1,0% 2 2,0% 
Have co-workers and supervisors at work been supportive and 
accommodating when they learned that you received psychiatric 
treatment? 
11 12,2% 11 12,2% 27 30,0% 23 25,6% 18 20,0% 
Have you been turned down for health insurance (or healthcare 
system) coverage on the basis of your psychiatric treatment 
history? 
66 81,5% 6 7,4% 7 8,6% 2 2,5% 0 0,0% 
Have you been denied a driver's license or other kind of permit 
when it was learned you had received psychiatric treatment? 74 80,4% 5 5,4% 8 8,7% 0 0,0% 5 5,4% 
Have you had the fact that you received psychiatric treatment used 
against you in legal proceedings? 77 77,8% 7 7,1% 4 4,0% 4 4,0% 7 7,1% 
Have you been treated with kindness and sympathy by law 
enforcement officers when they learned you had received 
psychiatric treatment? 
31 31,0% 10 10,0% 21 21,0% 25 25,0% 13 13,0% 
Have you avoided indicating on written applications that you 
received psychiatric treatment for fear that information would be 
used against you? 
50 46,3% 11 10,2% 20 18,5% 11 10,2% 16 14,8% 
 
 
31 
 
3.6 CESQ TOTAL SCORE CORRELATES AND ASSOCIATIONS 
 
After making sure the assumptions of Normality and equality of variances for CESQ total for both males and 
females were met (Kolmogorov-Smirnov tests, p=0.200 and Levene test, p=0.519) a two sample t-test for 
independent samples showed no significant differences in CESQ total score between female) and male 
participants (p=0.179), and between individuals living in the community and living in an institution 
(p=0.391).   
One way ANOVA showed no significant differences in CESQ total between participants with different marital 
status (single, married/living together and divorced/widow) p=0,517. 
There was a weak negative correlation between CESQ total score and both age (r=-0,288, p=0,001, n=119), 
and reported duration of illness (r= -0.211, p=0.023, n=116). Figure 24 summarizes the result for age and 
Figure 25 for reported duration of illness. 
A weak positive correlation was also found between CESQ total score and global functioning (r=0,284, 
p=0,015, n=73). Figure 26 shows this correlation. 
No significant correlation was found between CESQ total score and reported age of onset of illness (r= -
0.114, p= 0.223, n=117) 
 
3.7 STIGMA SCORE CORRELATES AND ASSOCIATIONS  
 
T-test for independent samples showed no significant differences in the Stigma score between female (M: 
23.4; SD 7.39) and male participants (p=0,252), between unemployed and employed individuals (p=0,213) 
and between individuals living in the community (M: 22.1 SD:6.25)  and living in an institution. (p=0,272) 
One way ANOVA showed no significant differences in the Stigma score between participants with different 
marital status (single, married/living together and divorced/widow) (p=0,703). 
Moreover the Stigma score was found not to be correlated neither with age (r= -0.121, p=0.189, n=119) nor 
with reported duration of illness (r= -0.063, p=0.499, n=116). 
No significant association was found between stigma score and global functioning (r=0.148, p=0.211, n=73). 
No significant correlation was found between stigma score and reported age of onset of illness (r= -0.107, 
p= 0.253, n=117) 
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3.8 DISCRIMINATION SCORE CORRELATES AND ASSOCIATIONS 
 
T-test for independent samples showed significant differences in discrimination score between female and 
male participants (p=0,001). Thus, male participants had a higher mean discrimination score. It also showed 
a statistically significant difference between discrimination score in individuals living in the community and 
living in an institution.(p=0,014) 
T-test for independent samples showed no significant differences in the Discrimination score between 
unemployed  and employed individuals. (p=0.687) 
One way ANOVA showed no significant differences in the Discrimination Score between participants with 
different marital status (single, married/living together and divorced/widow) (p=0,470). 
There was a moderate negative correlation between the Discrimination score and age  (r=-0,341, p=0,000, 
n=119), and a weak negative correlation between Discrimination score and reported duration of illness (r= -
0.211, p=0.023, n=116). Figure 27 and Figure 28 illustrate these correlations. 
A moderate positive correlation was also found between the Discrimination score and global functioning 
(ρ=0,344, p=0,003, n=73). Figure 29 pictures this correlation. 
No significant correlation was found between the Discrimination and reported age of onset of illness (r=-
0,75, p= 0,424, n=117) 
3.9 PSYCHOMETRIC PROPERTIES OF PORTUGUESE TRANSLATION 
3.9.1 Cronbach alpha 
 
Cronbach’s Alpha for the 20 items in CESQ scale was 0,801. 95% CI [0.746, 0.849] Item-total correlations 
were generally at least moderate, and the squared multiple regression generally confirmed that variance 
was moderately explained throughout. Cronbach’s alpha would not generally benefit from removal of any 
item. For the Stigma subscale, alpha was 0,754. 95% CI [0.683, 0.815] For the Discrimination subscale, alpha 
was 0.751. 95% CI [0.680, 0.811] 
3.9.2 Factor analysis 
 
Factor analysis was conducted on the data studied in this study. According to Bartlett’s test (value = 751.80 
and p<=0.001) the correlation matrix was not considered to be an identity matrix and was therefore suitable 
for further analysis. The KMO statistic was greater than 0.6 - 0.73. The MSA values for all individual items 
(anti-image correlation matrix) were greater than 0.60 and the absolute values of the off-diagonal were very 
low. Consequently, the factor analysis seemed appropriate. Table 8 displays the items and factor loadings 
for the rotated factors, with loadings less than 0.40 omitted to improve clarity. 
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After rotation the first factor accounted for 19% of the total variance and the second factor accounted for 
17%. The two factors accounted for around 36% of the total variance. 
 
Order of the items regarding factor loadings seems to replicate findings by Switáj et al in the first factor.70 
The first factor seems to index stigma loading most strongly on questions 2 (“Have you been treated as less 
competent by others when they learned you had received psychiatric treatment?”) 4 (“Have you been 
shunned or avoided by others when they learned you received psychiatric treatment?”), 5 (Have you been 
in situations where you heard others say unfavourable or offensive things about persons and their 
psychiatric disorders?) and 9 (Have you worried that others will view you unfavourably because you 
received psychiatric treatment?), with loadings in the first column, respectively, 0.715, .775, .754, .747. The 
second factor, which seemed to index discrimination, was composed of nine items with loadings in column 
2 of the table. 
Questions “Have you avoided telling others outsider of your immediate family that you have received 
psychiatric treatment?”, “Were friends understanding and supportive after learning that you receive 
psychiatric treatment?”,  “Have you been treated fairly by others who knew you received psychiatric 
treatment ?” and “Have you been denied psychiatric treatment because your health insurance or healthcare 
system was insufficient for you to pay the cost” seem not to fit in any of the factors in the model.  
 
Table 8 - Factor loadings for the rotated factors 
 Factor loadings  
 Stigma Discrimination Communalities 
Have you avoided telling others outsider of your 
immediate family that you have received psychiatric 
treatment? 
  0,072 
Have you been treated as less competent by others when 
they learned you had received psychiatric treatment? 
0,715  0,512 
Were friends understanding and supportive after learning 
that you receive psychiatric treatment? 
  0,033 
Have you been shunned or avoided by others when they 
learned you received psychiatric treatment? 
0,775  0,602 
Have you been in situations where you heard others say 
unfavourable or offensive things about persons and their 
psychiatric disorders? 
0,754  0,571 
Have you been advised to lower your expectations for 
accomplishments in life because you receive psychiatric 
0,623  0,41 
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treatment? 
Have you been treated fairly by others who knew you 
received psychiatric treatment ? 
  0,117 
Have you seen or read things in mass media about 
persons receiving psychiatric treatment and their 
psychiatric disorders which you found hurtful or 
offensive? 
0,647  0,435 
Have you worried that others will view you unfavourably 
because you received psychiatric treatment? 
0,747  0,562 
Have you been turned down for a job, for which you were 
qualified, when it was learned you received psychiatric 
treatment? 
 0,403 0,285 
Have you been denied psychiatric treatment because 
your health insurance or healthcare system was 
insufficient for you to pay the cost? 
  0,094 
Have you had difficulty renting an appartment or finding 
other housing when your psychiatric disorder was 
known? 
 0,521 0,271 
Have you been denied educational opportunities when it 
was learned that you received psychiatric treatment? 
 0,633 0,459 
Have you been excluded from volunteer or social 
activities when it was known you had received psychiatric 
treatment? 
 0,661 0,518 
Have co-workers and supervisors at work been supportive 
and accomodating when they learned that you received 
psychiatric treatment? 
 0,635 0,428 
Have you been turned down for health insurance 
coverage or for a loan on the basis of your psychiatric 
treatment history? 
 0,782 0,622 
Have you been denied a driver's license or other kind of 
permit when it was learned you had received psychiatric 
treatment? 
 0,591 0,377 
Have you had the fact that you received psychiatric 
treatment used against you in legal proceedings? 
 0,509 0,346 
Have you been treated with kindness and sympathy by 
law enforcement officers when they learned you had 
 0,431 0,185 
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received psychiatric treatment? 
Have you avoided indicating on written applications that 
you receives psychiatric treatment for fear that 
information would be used against you? 
0,441  0,306 
Eigenvalues 3,790 3,414  
% of variance 18,951 17,072  
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3.9.3 Test-retest reliability 
Test-retest reliability was assessed for 48 participants. The ICC for the CESQ total score was 
0.825 (95% CI of 0.709 to 0.898, p<0.001), while for the subscales/domains the ICCs obtained 
were: 0.833 (95% CI of 0.721 to 0.903, p<0.001) for stigma and 0.633 (95% CI of 0.430 to 0.775, 
p<0.001) for discrimination. 
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4 DISCUSSION 
4.1 IMPORTANCE OF THE STUDY 
To reduce stigma and discrimination is an increasingly recognized key objective in mental 
health policies around the world, and it has been the object of several programmes aimed 
specifically for that purpose.10,88  
Patient- reported outcome measurements have gained an important role and are rapidly 
becoming the mainstay of outcome measurement, both at interventions level89 and in quality 
improvement models.90. 
By turning stigma and discrimination into something measurable, one can more objectively 
assess the efficacy of interventions to tackle them both at national, regional and local level. 
Examples of these assessments of interventions include studies by Hansson and Markström91 
and by Campos et al.61.  
By measuring the personal experience of stigma in people with mental illness, one can make 
more comprehensive assessments, including the service users’ perspective.  
Focusing on mental health services research, if we applied Donabedian’s framework of 
structure, processes and outcomes92 to stigma,  the experience of stigma could, thus, be 
viewed as a patient reported outcome measurement. Hence, it is extremely important both to 
provide assessments of stigma according to the service users’ perspective and also to develop 
psychometric instruments that can feasibly measure the experience of stigma at both 
international and national levels. That were precisely the aims of our study. 
Previous studies of stigma in Portugal are different from current study. 
Some of the researchers study the potentially stigmatizing group – in other words, the general 
population, or subgroups within it, regarding several public stigma domains: 
 Loureiro et al. researched attitudes and behaviour in the general population55 and 
mental health literacy in a specific group of the general population (adolescents and 
young adults).55,57,93 
 Palha, Campos et al. also focused on mental health literacy in adolescents, by studying 
interventions designed to improve it. 60 They also assessed attitudes towards mental 
illness in a population of university students.59,88 
 Chambers, Botelho et al. study attitudes towards mental illness in a sample of mental 
health nurses.62 
The population in our study belongs to a group that is stigmatized rather than stigmatizing. In 
other words, we have studied personal stigma rather than public stigma. 
Gonçalves-Pereira et al. studied, among other variables, stigma in the caregivers of patients 
with schizophrenia.63  - a group that is also stigmatized, but which is different from ours: in fact, 
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the population in our study is made of people with severe mental illness, instead of their 
caregivers. 
We acknowledge other studies that have specifically researched into stigma in people with 
mental illness and their personal stigma. The Maristan study  measured self stigma, perceived 
discrimination regarding mental health professionals, and patients’ perceptions on mental 
health services and informal networks.48 However our study measures variables in a different 
domain, according to Brohan et al.’s categorization30 – actual experiences of stigma and 
discrimination. Sousa et al.65 studied the relationship between self-stigma and recovery 
potential in schizophrenia. Participants had moderate scores in experiences of discrimination 
subscale in ISMI. However, ISMI is not specific to experiences of stigma, measuring mainly self-
stigma constructs.30 
In sum, we approached stigma in a different manner. In order to do so, we used CESQ, the most 
well-known scale that measures experiences of stigma at international level, according to the 
revision by Brohan et al.30. 
4.2 DISCUSSION OF CESQ SCORING RESULTS 
In our results, CESQ stigma subscale items were highly scored in general, with the majority of 
patients having stigmatizing experiences at least sometimes. We should also note the relatively 
high reported frequencies of items describing positive experiences. The most reported negative 
experience was being in situations where one hears other people saying unfavourable things 
about people with mental illness. The second most reported stigma experience was being 
worried about other people’s opinion after they have learned the respondent had received 
psychiatric treatment. 
The high frequencies of these reports of the experience of stigma suggest that public stigma 
against mental illness is still rooted in Portuguese society and triggers stigmatizing behaviours 
perceptible to patients. 
Positive experiences are also worth noting: 78% of the participants consider that, at least 
sometimes, friends were understanding and supportive after learning they had received 
psychiatric treatment and 77% of the patients feel that others treat them fairly.  
The high prevalence of both positive and negative experiences can well correlate with the 
previous study about attitudes towards mental illness by Loureiro et al.55, in which public 
tolerability regarding mental illness was high, but beliefs about dangerousness and incurability 
persisted.   
Reported discrimination experiences’ frequency is relatively low. Nevertheless, the fact that 
more than forty percent of the respondents state that at least sometimes, they have avoided 
indicating on written application that they received psychiatric treatment for fear that 
information would be used against them, is, in our opinion, an indicator of the prejudice that 
still exists in the Portuguese society. 
More than forty percent of the respondents report that they never (or seldom) have been 
treated with kindness and sympathy by law enforcement officers when they learned they had 
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received psychiatric treatment. In Portugal, in a study in the so-called Metropolitan Psychiatric 
Emergency in  Porto area, 18% of total observed patients in the emergency room have been 
shown to  be involuntary commited.94Emergency involuntary commitment has been shown to 
account for up to 90% of total involuntary commitments in Lisbon area.95 Law enforcement 
officers have a very important role in taking people with mental illness to the emergency room 
for examination by psychiatrists. Therefore, this finding could raise some concerns, as also 
stated below. 
In both stigma an discrimination subscales, frequencies of responses to items were not as high 
as reported by Wahl29, possibly due to the fact that Wahl’s study is based on a NAMI affiliated 
sample, perhaps a more empowered group or at least more aware of stigma issues.  
Sample in our study comprised patients from both inpatient and outpatient clinics. In that 
sense, it was more heterogeneous than the one in Dickerson et al.’s study.35, who recruited 
patients at an outpatient clinic, and similar to sample from study by Switaj et al.68 Frequencies  
in the stigma subscale in our study were grossly comparable to those reported by Dickerson et 
al.,35 and Switaj et al.  
Our sample tended to report a slightly lower frequency of discrimination experiences, than the 
sample in the study by Dickerson et. al.35 That effect is, maybe, attributable to the different 
provenience of our sample, as discussed below. 
4.3 PSYCHOMETRIC PROPERTIES OF PORTUGUESE VERSION OF CESQ 
Regarding psychometric properties, CESQ was already in compliance with criteria defined by 
Terwee et al concerning content validity. However, some of its psychometric properties were 
not yet fully determined: test-retest reliability,  criterion validity, and factorial validity. 
The Portuguese version of CESQ did not have its psychometric properties documented. In fact, 
no studies involving the Portuguese version of CESQ had been published until now. 
This study aimed to provide a contribution to assessment of psychometric properties of CESQ, 
as well as those in its Portuguese version, with a special emphasis on reliability measures. 
Regarding face and content validity, the Portuguese translation of CESQ was discussed with 
mental health professionals from ARIA and Casa de Saúde da Idanha, who provided valuable 
contributions to refinement of translation, wording and phrasing.  
Regarding construct validity, results from our study do not replicate exactly previous construct 
validity data, as we will detail further in this discussion. 
In factor analysis most of the items in the questionnaire seemed to fit a two factor model, in 
line with the original factors. Also, factors with the highest loadings seem to match those 
obtained by Switaj et al. in their factor analysis of stigma subsection of the scale.70 
Nevertheless, four of the items did not fit in any of the two factors. 
Cronbach’s  alpha of CESQ scale was 0.801. This value for the whole scale is not reported in the 
literature. 
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For the stigma subscale, Cronbach’s alpha was 0.754, which is comparable to results by Switaj 
et al.68   
Regarding the discrimination subscale, Cronbach’s alpha in our sample was 0.751. Switaj et al 
stated that the value for alpha in discrimination subscale in their sample was 0.63.70 Our value 
is good82 and far better than the one obtained by other authors. We do not have a clear 
explanation for this fact. 
Test retest reliability was, for the first time at the international level, assessed in a study using 
CESQ. Criteria suggested by Terwee et al are an ICC of at least 0.70, measured in a sample of at 
least fifty patients. Our assessment is only two participants short to meet exactly Terwee 
sample requirements 31. However, values for stigma and CESQ total scale obtained were 
considered acceptable.31,96  Test retest reliability for discrimination subscale is lower than the 
limit of acceptability.  
We should stress that issues with psychometric properties of the discrimination section were 
also found in Switaj et al.’s study. However, our sample’s Cronbach Alpha regarding that section 
is better than the one reported by those authors. 
4.4 CORRELATES  OF STIGMA AND DISCRIMINATION 
Regarding computed scores, there was no difference in stigma score or total CESQ score 
between individuals living in an institution and individuals living in the community. 
This seems to be in line with evidence from previous studies using CESQ.35,68–70  
However, our study found that individuals living in an institution appeared to report a lower 
discrimination score than individuals living in the community.  
Differences in discrimination scores might be related to the fact people in an institution are 
integrated and more protected from contact with stigmatizing individuals and, thus, from 
discriminatory experiences than individuals in the community.  
Dickerson et al.35 found no significant association between stigma (or discrimination) scores 
and degree of community integration. Switaj et al.68 also found no significant association 
between the clinical setting and stigma scores. 
Although not consistent with this evidence published by those authors, findings from a study by 
Angermeyer et al.27are apparently in line with our result. That study was made immediately  
after the reform of mental health care in Germany. In that reform, old  state psychiatric 
hospitals were closed and modern university hospitals were built, performing a shift from a 
custodial to a community based mental health care.  As one of the motives of the reform was 
that patients in psychiatric hospitals experienced more stigma,  it was hypothesized that  
perceived devaluation was higher in patients attending psychiatric hospitals than those 
attending university hospitals. Unexpectedly, the result was that perceived devaluation was 
higher in patients attending university hospitals.  
A possible explanation to the fact this difference occurs with discrimination score and it does 
not occur with stigma score or CESQ total score might be the fact that some of the items, such 
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as “Have you had difficulty renting an apartment or finding other housing when your psychiatric 
disorder was known?”, “Have co-workers and supervisors at work been supportive and 
accommodating when they learned that you received psychiatric treatment?” ,“Have you been 
turned down for health insurance coverage on the basis of your psychiatric treatment history?” 
or “Have you been treated with kindness and sympathy by law enforcement officers when they 
learned you had received psychiatric treatment?” 
Male gender was apparently associated with higher levels of discrimination experiences, but 
not of stigma or of CESQ total scores. Previous studies using CESQ failed to document any 
significant association between these variables. However, in Livingston et al.’s review23, four of 
38 reviewed studies exploring associations between gender and stigma, male patients 
experienced more stigma than female, while in three of those studies, female patients 
experienced more stigma than males. We should note that 31 those studies failed to document 
any significant association. Findings from our study may suggest that mental illness in females is 
more socially accepted. 
Concerning age, we found an apparent weak negative correlation with total CESQ score and an 
apparent moderate negative correlation with the discrimination score. There seems to be no 
significant correlation with stigma score. Livingston et al23 had already pointed the 
inconsistency of the studies regarding associations between age and stigma.  
Reported duration of illness is a variable that is related to age. There appeared to be a weak 
negative correlation with CESQ total and discrimination scores, but again not with stigma. 
Reported age of onset of illness was not significantly correlated with CESQ total score, 
discrimination or stigma. Hence, this suggests that the correlation of reported duration of 
illness with stigma scores may be confounded by age. 
An hypothetical explanation to the effects of age on CESQ scores would be that as people get 
older they tend to develop coping mechanisms in order to overcome discrimination, or not to 
expose themselves so easily to discrimination experiences.  
Switaj et al.68 established an apparent correlation between stigma scores and the age of 
becoming ill. A possible explanation point by the authors is that “becoming ill at a younger age, 
when one’s personal circumstances are not quite established and one’s social network is still 
underdeveloped, might make it difficult to master the resources necessary for avoiding 
negative social responses or facing up to them, which in turn makes mentally ill people more 
exposed to rejection”. We apparently found no significant correlation in our study between 
stigma score, discrimination score, CESQ total score and the latter variable and, thus, we have 
not been able to replicate their result.  We are unable to find explanation for this result. 
No association was found between stigma and discrimination scores and employment status, or 
marital status. This is similar to most of studies in the literature concerning internalized 
stigma23 and to previous studies using CESQ.35,68–70,73 
Studies involving CESQ reported an apparent lack of correlation between experiences of stigma 
and global functioning 35,68. 
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Lundberg et al. have reported a moderate inverse correlation between prevalence of 
devaluation/discrimination and global functioning.26 Explanations for that finding, according to 
the same authors, are that being labelled with a mental illness triggers expectations of rejection 
that may disrupt social interaction and impair social and psychological functioning.  
Surprisingly, we found a moderate positive correlation between the discrimination score and 
global functioning, and a weak positive correlation between CESQ total score and global 
functioning.  Our hypothesis to explain it is that maybe global functioning was associated in our 
sample with an increased awareness and increased reporting of discrimination experiences. 
Another possible explanation is the fact that participants with lower global functioning scores 
tended to live in an institution. These participants, as already mentioned, may be more 
“protected” from discrimination experiences. 
4.5 LIMITATIONS OF THE STUDY 
We consider that this study globally met its aims.  
However, when applying the CESQ measure after the pilot study, we found that some of the 
patients had difficulty understanding the questions. None of the questionnaires, however, had 
missing data. Thus, we can argue that Portuguese translation is comprehensible. 
Moreover, our sample was a convenience non-randomized sample, and it was confined to 
greater Lisbon areas. Differences in the interpretation of items might exist in other regions of 
Portugal. 
Subsamples were heterogeneous and this limited statistical power. There was also an 
underreporting of diagnosis in the ARIA sample, which prevented better comparisons of CESQ 
scores among diagnostic groups. 
A multivariate analysis should have been done in order to assess if the correlation of reported 
duration of illness with stigma scores is confounded by age. 
Discriminant and convergent validity of CESQ scale was not thoroughly assessed. Other related 
constructs might be measured besides GAF and constructs within socio-demographic and 
clinical data.  
These issues do not allow generalizability. Thus, results of this study should be taken with 
caution. 
4.6 FURTHER RESEARCH AND IMPLICATIONS OF THE STUDY 
 
This study is the first to explore direct experiences of stigma and discrimination in a Portuguese 
clinical sample. 
Further replications should use larger samples, preferably from multiple regions in Portugal and 
from multiple settings. 
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The high frequency of responses to positive experiences in the stigma section, should prompt 
us to investigate the role of social support/informal care networks in stigma. It would be 
interesting to apply in the same study both CESQ and a scale that measures these constructs, 
such as MARISTAN stigma scale.48 
Also interesting would be to explore relationships between experienced stigma and other 
related constructs in personal stigma – such as self-stigma and perceived stigma. 
Another interesting avenue of research, at the national level, would be to assess covariates 
between experiences of stigma and its consequences.  
Regarding the validity and psychometric properties of the CESQ measure, further work should 
be pursued in order to test the ecological validity of the translation. Therefore, we think there 
must be further discussions, preferably within groups of patients, in order to foster adaptations 
to the Portuguese language and culture. 
Other outcomes should be assessed in order to enhance data regarding discriminant and 
convergent validity of the Portuguese translation. We suggest measuring constructs such as 
years of schooling, quality of life, general psychopathology and depression.  
Although there is no “gold standard” regarding measures of experiences of stigma, it seems 
also advisable to apply CESQ and other instruments, such as ISMI and DISC that measure the 
same construct, (apart from other constructs) in order to enhance criterion validity.  
Test-retest reliability assessment could be replicated, using a larger sample. 
From the services organization standpoint, results of this study, if replicated, might provide a 
rationale for designing specific interventions in order to tackle stigma, and aim them at selected 
groups. 
For example, involvement of stakeholders within the media might prove important, as more 
than 40% of the patients report hearing or reading hurtful or offensive depictions of mental 
illness. Another target group for actions might be law enforcement officers.   
As experiences of stigma actually reflect the individual impact of public stigma, CESQ can be 
explored as an outcome measurement for anti-stigma policies and programmes.  
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5 CONCLUSIONS 
 
This study provides an insight into levels  of experienced stigma and discrimination in Portugal. A 
majority of patients in our sample had faced, at least sometimes, such experiences. 
In our study, discrimination experiences seem to be positively associated to male gender and living in 
the community and inversely correlated with age and duration of illness. Possible explanations for these 
associations might be, respectively: better social acceptation of mental illness in females, possible 
protection of institutionalized patients concerning discrimination experiences and age related 
development of coping mechanisms to deal with or to avoid discrimination. 
There is also an apparent positive correlation between discrimination and global functioning, maybe due 
to increased awareness and increased reporting of discrimination experiences. 
These results prompt research to explore other covariates, such as the role of informal networks. 
We also aimed to contribute to the assessment of the psychometric properties of the Consumer 
Experiences of Stigma Questionnaire-CESQ, using this authorized Portuguese translation. Regarding this, 
we have successfully assessed test-retest reliability for the first time internationally, obtaining good 
results. We also confirmed a good internal consistency, and the overall factorial validity of the 
previously proposed stigma and discrimination subscales. 
Thus we provided a valid contribute to the assessment of CESQ psychometrics, completing data 
concerning its reliability. 
Experiences of stigma are, at the individual level, the consequence of public stigma. Therefore, they can 
be studied as an outcome measurement, when evaluating interventions developed to tackle stigma, 
both at national and local level. 
Further development of tools that measure experiences of stigma, as well as other domains of 
individual stigma are, thus, crucial for ensuring patients to have the “highest attainable 
standard of care”, as the Convention on the Rights of People with Disabilities states.7 
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1 Disorders’ definitions in the International Classification of 
Diseases - 1077 
 
 
 F20 – Schizophrenia  
The schizophrenic disorders are characterized in general by fundamental and 
characteristic distortions of thinking and perception, and affects that are inappropriate 
or blunted. Clear consciousness and intellectual capacity are usually maintained 
although certain cognitive deficits may evolve in the course of time. The most important 
psychopathological phenomena include thought echo; thought insertion or withdrawal; 
thought broadcasting; delusional perception and delusions of control; influence or 
passivity; hallucinatory voices commenting or discussing the patient in the third person; 
thought disorders and negative symptoms. 
The course of schizophrenic disorders can be either continuous, or episodic with 
progressive or stable deficit, or there can be one or more episodes with complete or 
incomplete remission. The diagnosis of schizophrenia should not be made in the 
presence of extensive depressive or manic symptoms unless it is clear that 
schizophrenic symptoms antedate the affective disturbance. Nor should schizophrenia 
be diagnosed in the presence of overt brain disease or during states of drug intoxication 
or withdrawal. Similar disorders developing in the presence of epilepsy or other brain 
disease should be classified under F06.2, and those induced by psychoactive substances 
under F10-F19 with common fourth character .5. 
 F22.0 - Delusional disorder  
A disorder characterized by the development either of a single delusion or of a set of 
related delusions that are usually persistent and sometimes lifelong. The content of the 
delusion or delusions is very variable. Clear and persistent auditory hallucinations 
(voices), schizophrenic symptoms such as delusions of control and marked blunting of 
affect, and definite evidence of brain disease are all incompatible with this diagnosis. 
However, the presence of occasional or transitory auditory hallucinations, particularly in 
elderly patients, does not rule out this diagnosis, provided that they are not typically 
schizophrenic and form only a small part of the overall clinical picture. 
 F25 - Schizoaffective disorders  
Episodic disorders in which both affective and schizophrenic symptoms are prominent 
but which do not justify a diagnosis of either schizophrenia or depressive or manic 
episodes. Other conditions in which affective symptoms are superimposed on a pre-
existing schizophrenic illness, or co-exist or alternate with persistent delusional 
disorders of other kinds, are classified under F20-F29. Mood-incongruent psychotic 
symptoms in affective disorders do not justify a diagnosis of schizoaffective disorder. 
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 F 31 – Bipolar affective disorder 
A disorder characterized by two or more episodes in which the patient's mood and 
activity levels are significantly disturbed, this disturbance consisting on some occasions 
of an elevation of mood and increased energy and activity (hypomania or mania) and on 
others of a lowering of mood and decreased energy and activity (depression). Repeated 
episodes of hypomania or mania only are classified as bipolar. 
 F33 - Depressive episode  
In typical mild, moderate, or severe depressive episodes, the patient suffers from 
lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, 
interest, and concentration is reduced, and marked tiredness after even minimum effort 
is common. Sleep is usually disturbed and appetite diminished. Self-esteem and self-
confidence are almost always reduced and, even in the mild form, some ideas of guilt or 
worthlessness are often present. The lowered mood varies little from day to day, is 
unresponsive to circumstances and may be accompanied by so-called "somatic" 
symptoms, such as loss of interest and pleasurable feelings, waking in the morning 
several hours before the usual time, depression worst in the morning, marked 
psychomotor retardation, agitation, loss of appetite, weight loss, and loss of libido. 
Depending upon the number and severity of the symptoms, a depressive episode may 
be specified as mild, moderate or severe. 
 F 32.3 Severe depressive episode with psychotic symptoms  
An episode of depression as described in F32.2, but with the presence of 
hallucinations, delusions, psychomotor retardation, or stupor so severe that 
ordinary social activities are impossible; there may be danger to life from suicide, 
dehydration, or starvation. The hallucinations and delusions may or may not be 
mood-congruent. 
 
55 
 
2 EXAMPLES OF ITEMS IN WAHL’S ORIGINAL VERSION29 
 
I have worried that others will view me unfavorably because I am a consumer. 
I have been in situations where I have heard others say unfavorable or offensive things about 
consumers and their illnesses. 
I have seen or read things in the mass media (e.g., television, movies, books) about consumers and 
their illnesses that I find hurtful or offensive. 
3 EXAMPLES OF ITEMS IN THE VERSION MODIFIED BY DICKERSON ET AL.35 
Have you avoided telling others outsider of your immediate family that you have received 
psychiatric treatment? 
Have you been treated as less competent by others when they learned you had received psychiatric 
treatment? 
Were friends understanding and supportive after learning that you receive psychiatric treatment? 
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4 FIGURES 
 
 
 
 
Figure 1 – QQ plot - patient age – Idanha 
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Figure 2 - Box plot - age and local 
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Figure 3 - Reported age of diagnosis 
 
59 
 
 
Figure 4 - Reported age of diagnosis by local 
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Figure 5 -  Reported duration of illness by local 
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Figure 6 - Box plot - CESQ total and Gender 
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Figure 7 - Box plot - CESQ total and occupational status 
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Figure 8 - Box plot - CESQ total and institutionalization 
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Figure 9 - Box plot - CESQ total and marital status 
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Figure 10 - Box plot - Stigma score and gender 
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Figure 11- Box plot - Stigma score and occupational status 
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Figure 12 - Box plot - Stigma score and institutionalization 
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Figure 13- Box plot - Stigma score and marital status 
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Figure 14- Box plot - Discrimination score and gender 
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Figure 15- Box plot - Discrimination score and employment status 
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Figure 16- Box plot - Discrimination score and institutionalization 
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Figure 17 - Box plot - Discrimination score and marital status 
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Figure 18 - Histogram for CESQ Total Score 
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Figure 19 - Normal QQ Plot of the CESQ total score 
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Figure 20 - Histogram for score of the stigma subscale 
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Figure 21 - Normal QQ Plot of the stigma subscale 
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Figure 22 - Histogram for score of the discrimination subscale 
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Figure 23 - Normal QQ Plot of the discrimination subscale 
 
 
79 
 
 
Figure 24 - Scatter Plot - Total CESQ Score and age 
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Figure 25 - Scatter Plot - Total CESQ Score and reported duration of illness 
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Figure 26 - Scatter Plot - Total CESQ Score and global functioning 
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Figure 27 - Scatter Plot - Discrimination score and age 
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Figure 28 - Scatter Plot - Discrimination score and reported duration of illness 
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Figure 29 - Scatter Plot - Discrimination score and global functioning 
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5 OTHER TABLES 
 
Table 9 - Detailed demographic characteristics of the sample 
  ARIA Idanha FAPS 
n  49 42 31 
Gender 
 
Female ( %) 13 (26,5%) 36 (85,7%) 5 (16,1%) 
Male ( %) 36 (73,5%) 6 (14,3%) 26 (83,9%) 
Age 
Mean: 39,54 54,88 39,32 
SD: 10,572 10,816 11,047 
Range 18-64 34-96 23-63 
Marital status 
Single (%) 43 (87,8%) 30 (71,4%) 25 (80,6%) 
Married / Living together (%) 1 (2,0%) 4 (9,5%) 4 (12,9%) 
Divorced / Widow (%) 5 (10,2%) 8 (19,0%) 2 (6,5%) 
Living status 
Living alone 11 (22,9%) 3 (7,0%) 4( 12.9%) 
Living with family support 31 (64,6%) 5 (11,9%) 28 (87.1%) 
Homeless 1 (1,7% 0 (0%) 0 (0%) 
Living in an institution 5 (8,3%) 34 (81,0%) 0 (0%) 
Occupational status 
Unemployed / Retired 35 (74.5%) 36 (85.7%) 28 (90.3%) 
Employed / In professional training 12 (25.5%) 6 (14.3%) 3 (9.7%) 
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Table 10 – Detailed clinical characteristics of the three subsamples 
  ARIA Idanha FAPS 
  n % n % n % 
Diagnosis 
 
Schizophrenia (F20.0) 9 64,3 23 54,8 27 87,1 
Bipolar disorder (F31) 2 14,3 10 23,8 0 0 
Schizoaffective disorder (F25) 2 14,3 4 9,5 2 6,5 
Depression (F32.3) 1 7,1 5 11,9 0 0 
Delusional disorder (F22) 0 0 0 0 2 6,5 
 n for diagnosis 14 100 42 100 31 100 
Reported age at onset of 
illness 
(years) 
 
Mean 23,59 26,17 21.42 
SD 8.162 9.594 6.682 
Range 14-55 13-57 11-39 
 n for reported age of onset of illness 44 42 31 
Reported duration of 
illness 
(years) 
 
Mean: 15,7 28,71 17,90 
SD: 9,471 13,883 11,703 
Range 2-39 5-77 2-47 
N for reported duration of illness 43 42 31 
Global Functioning 
(GAF Score) 
Mean 
Not reported 
34.8 53.8 
SD 9.02 14.20 
Range 21-64 30-75 
N for Global function (GAF score) 42 31 
 
